CompletedPhase 4NCT00139828

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Prothya Biosolutions
Principal Investigator
E P Mauser-Bunschoten, MD, PdD
UMC Utrecht, Van Creveldkliniek, Utrecht, The Netherlands
Intervention
human coagulation Factor IX(drug)
Enrollment
12 enrolled
Eligibility
6 years · All sexes
Timeline
2003 – 2007

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00139828 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials